- €226.73m
- €1.24bn
- €717.02m
- 32
- 44
- 49
- 34
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 806 | 824 | 748 | 740 | 717 |
Cost of Revenue | |||||
Gross Profit | 730 | 754 | 701 | 699 | 663 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 762 | 783 | 728 | 727 | 700 |
Operating Profit | 43.8 | 41.3 | 20.2 | 13 | 17 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 30.5 | 29.3 | 9.11 | 6.13 | 12.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 22 | 21.5 | 2.17 | 5.84 | 9.02 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 22 | 21.5 | 2.17 | 5.84 | 9.02 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 22 | 21.5 | 2.17 | 5.84 | 9.02 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.07 | 1.04 | 0.105 | 0.283 | 0.438 |
Dividends per Share |